Pharma major Dr Reddy’s Laboratories' US subsidiary, Promius Pharma, has launched Sernivo (betamethasone dipropionate) Spray in the US.

Sernivo Spray, a prescription topical steroid approved by the Food and Drug Administration (FDA) in February of 2016, is indicated for the treatment of mild to moderate plaque psoriasis in patients 18 years of age or older.

This was announced by Raghav Chari, Executive Vice-President, Proprietary Products Group at Dr Reddy’s Laboratories in a release issued here on Wednesday.

social-fb COMMENT NOW